Prothrombin G20210A and methylenetetrahydrofolate reductase C677T polymorphisms in peripheral capillary nonperfusion: a case report

被引:0
作者
Wathek, Chaima [1 ]
Mrad, Meriem [2 ]
Ben Abdessalem, Nadia [1 ]
Maalej, Afef [1 ]
Gritli, Nasreddine [2 ]
Gabsi, Salem [1 ]
Rannen, Riadh [1 ]
Fekih-Mrissa, Najiba [2 ]
机构
[1] Mil Hosp Tunisia, Dept Ophthalmol, Tunis, Tunisia
[2] Mil Hosp Tunisia, Dept Hematol, Mol Biol Lab, Tunis, Tunisia
关键词
methylenetetrahydrofolate reductase; peripheral capillary; prothrombin gene; RETINAL VEIN OCCLUSION; FACTOR-V-LEIDEN; METHYLENE TETRAHYDROFOLATE REDUCTASE; PLASMA HOMOCYSTEINE; VENOUS THROMBOSIS; TUNISIAN PATIENTS; ARTERY-OCCLUSION; ISCHEMIC-STROKE; RISK-FACTOR; MUTATION;
D O I
10.1097/MBC.0000000000000311
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The G20210A mutation in the prothrombin gene is an established risk factor for venous thrombosis. However, there is some controversy as to the role played by this mutation in arterial thrombotic disease. The association of peripheral capillary nonperfusion with prothrombin G20210A mutation has never been reported before. We present the case of 34-year-old man who presented with peripheral capillary nonperfusion. The fundus examination of his right eye revealed an epiretinal membrane, peripheral (mainly temporally) retinal haemorrhages, exudates and microaneurismal alterations of the vascular bed. Fluorescein angiography of his right eye demonstrated an extended area of capillary nonperfusion distal to the microaneurismal lesions. Evaluation revealed mutations of the G20210A prothrombin and MTHFR genes. Screening for hereditary thrombophilia should be considered, regardless of patient age, in patients with peripheral retinal ischemia. The prothrombin G20210A mutation, a genetic risk factor, may be associated with peripheral capillary nonperfusion.
引用
收藏
页码:682 / 684
页数:3
相关论文
共 21 条
  • [1] Retinal artery occlusion in a patient with factor V Leiden and prothrombin G20210A mutations
    Ben-Ami, R
    Zeltser, D
    Leibowitz, I
    Berliner, SA
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 2002, 13 (01) : 57 - 59
  • [2] Raised plasma homocysteine as a risk factor for retinal vascular occlusive disease
    Cahill, M
    Karabatzaki, M
    Meleady, R
    Refsum, H
    Ueland, P
    Shields, D
    Mooney, D
    Graham, I
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2000, 84 (02) : 154 - 157
  • [3] Dose-related association of MTHFR 677T allele with risk of ischemic stroke -: Evidence from a cumulative meta-analysis
    Cronin, S
    Furie, KL
    Kelly, PJ
    [J]. STROKE, 2005, 36 (07) : 1581 - 1587
  • [4] Recurrent optic nerve head infarctions associated with combined factor V Leiden- and factor II:G20210A-mutation
    Cursiefen, C
    Schönherr, U
    Schwender, S
    Grossmann, R
    [J]. ACTA OPHTHALMOLOGICA SCANDINAVICA, 1999, 77 (06): : 625 - 627
  • [5] Hyperhomocysteinemia and the methylenetetrahydrofolate reductase 677C-T mutation in patients under 50 years of age affected by central retinal vein occlusion
    Di Crecchio, L
    Parodi, MB
    Sanguinetti, G
    Iacono, P
    Ravalico, G
    [J]. OPHTHALMOLOGY, 2004, 111 (05) : 940 - 945
  • [6] Methylenetetrahydrofolate Reductase (C677T and A1298C) Polymorphisms, Hyperhomocysteinemia, and Ischemic Stroke in Tunisian Patients
    Fekih-Mrissa, Najiba
    Mrad, Meriem
    Klai, Sarra
    Mansour, Malek
    Nsiri, Brahim
    Gritli, Nasreddine
    Mrissa, Ridha
    [J]. JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2013, 22 (04) : 465 - 469
  • [7] The heterozygous 20210 G/A prothrombin genotype is associated with early venous thrombosis in inherited thrombophilias and is not increased in frequency in artery disease
    Ferraresi, P
    Marchetti, G
    Legnani, C
    Cavallari, E
    Castoldi, E
    Mascoli, F
    Ardissino, D
    Palareti, G
    Bernardi, F
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (11) : 2418 - 2422
  • [8] A CANDIDATE GENETIC RISK FACTOR FOR VASCULAR-DISEASE - A COMMON MUTATION IN METHYLENETETRAHYDROFOLATE REDUCTASE
    FROSST, P
    BLOM, HJ
    MILOS, R
    GOYETTE, P
    SHEPPARD, CA
    MATTHEWS, RG
    BOERS, GJH
    DENHEIJER, M
    KLUIJTMANS, LAJ
    VANDENHEUVEL, LP
    ROZEN, R
    [J]. NATURE GENETICS, 1995, 10 (01) : 111 - 113
  • [9] Arterial wall thickness and the risk of recurrent ischemic events in carriers of the prothrombin G20210A mutation with clinical manifestations of atherosclerosis
    Gerdes, VEA
    ten Cate, H
    de Groot, E
    Kwa, VIH
    Prins, MH
    Reitsma, PH
    Büller, HR
    Brandjes, DPM
    [J]. ATHEROSCLEROSIS, 2002, 163 (01) : 135 - 140
  • [10] Ocular Vascular Thrombotic Events: A Diagnostic Window to Familial Thrombophilia (Compound Factor V Leiden and Prothrombin Gene Heterozygosity) and Thrombosis
    Glueck, Charles J.
    Wang, Ping
    [J]. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2009, 15 (01) : 12 - 18